IP Library Patent Application 11151035
Patent Application
App. No. 11/151,035

Non-halogenated hydroxyalkyl-substituted phenol compounds, antimicrobial compositions containing the same, and methods of using the same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/151,035
Abstract

A antimicrobial compound, compositions containing the same, and method of using the same for reducing the presence of microorganism on a substrate or in a fluid environment comprising an antimicrobial effective carrier and at least one antimicrobial compounds including non-halogenated hydroxyalkyl-substituted phenol compounds.

Claims (30)

1 . A compound of Formula I:

Wherein R 1 and R 5 are each independently selected from the group consisting of hydrogen, a C 2 through C 12 straight chain alkyl, a C 3 through C 12 branched alkyl group, and a C 3 through C 6 cycloalkyl group; and

R 2 r 3 and R 4 are each independently selected from the group consisting of hydrogen, a C 3 through C 12 straight chain alkyl optionally substituted with hydroxyl, a C 3 through C 12 branched alkyl optionally substituted with hydroxyl, and a C 3 through C 6 cycloalkyl optionally substituted with hydroxyl:

With the proviso that

At least one of R 1 , R 2 , R 3 , R 4 and R 5 are selected from the group consisting of a C 2 through C 12 straight chain alkyl, a C 3 through C 12 branched alkyl group, and a C 3 through C 6 cycloalkyl group; and

At least one of R 2 , R 3 , and R 4 are selected from the group consisting of a C 3 through C 12 straight chain hydroxyalkyl, a C 3 through C 12 branched hydroxyalkyl or a C 3 through C 6 hydroxycycloalkyl; and

each of R 1 , R 2 , R 3 , R 4 and R 5 are not tert-butyl.

2 . The compound of claim 1 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 8 straight chain alkyl, a C 3 through C 8 branched alkyl group, and a C 3 through C 6 cycloalkyl group.

3 . The compound of claim 1 wherein at least one of R 2 , R 3 , and R 4 is selected from the group consisting of a C 3 through C 8 straight chain hydroxyalkyl, a C 3 through C 8 branched hydroxyalkyl or a C 3 through C 6 hydroxycycloalkyl.

4 . The compound of claim 2 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 8 straight chain alkyl.

5 . The compound of claim 2 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 8 branched alkyl.

6 . The compound of claim 2 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 6 cycloalkyl.

7 . The compound of claim 2 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of methylethyl and 2-methylpropyl.

8 . The compound of claim 3 wherein at least one of R 2 , R 3 , and R 4 is selected from the group consisting of a C 3 through C 8 straight chain hydroxyalkyl.

9 . The compound of claim 3 wherein at least one of R 2 , R 3 , and R 4 is a C 3 through C 8 branched hydroxyalkyl.

10 . The compound of claim 3 wherein at least one of R 2 , R 3 , and R 4 is selected from the group consisting of a C 3 through C 6 hydroxycycloalkyl.

11 . The compound of claim 3 wherein at least one of R 2 , R 3 , and R 4 is selected from the group consisting of 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxybutyl, 2-hydroxybutyl, 3-hydroxybutyl, and 4-hydroxybutyl.

12 . The compound of claim 2 wherein R 3 is selected from the group consisting of a C 3 through C 12 straight chain hydroxyalkyl, a C 3 through C 12 branched hydroxyalkyl or a C 3 through C 6 hydroxycycloalkyl.

13 . An antimicrobial composition comprising an antimicrobial acceptable carrier and an effective antimicrobial amount of at least one compound of Formula (II):

Wherein R 1 , R 2 , R 3 , R 4 and R 5 are each independently selected from the group consisting of hydrogen, a C 1 through C 12 straight chain alkyl optionally substituted with hydroxyl, a C 3 through C 12 branched alkyl optionally substituted with hydroxyl, and a C 3 through C 6 cycloalkyl optionally substituted with hydroxyl;

With the proviso that

At least one of R 1 , R 2 , R 4 , R 3 and R 5 are selected from the group consisting of a C 1 through C 12 straight chain alkyl, a C 3 through C 12 branched alkyl group, and a C 3 through C 6 cycloalkyl group; and

At least one of R 1 , R 2 , R 4 , R 3 and R 5 are selected from the group consisting of a C, through C 12 straight chain hydroxyalkyl, a C 3 through C 12 branched hydroxyalkyl or a C 3 through C 6 hydroxycycloalkyl.

14 . The antimicrobial composition of claim 13 wherein the antimicrobial effective carrier is selected from the group consisting of water, saline, alcohol, glycerin, propylene glycol, mineral oil, petrolatum and mixtures thereof.

15 . The antimicrobial composition of claim 13 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 8 straight chain alkyl, a C 3 through C 8 branched alkyl group, and a C 3 through C 6 cycloalkyl group.

16 . The antimicrobial composition of claim 13 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 8 straight chain hydroxyalkyl, a C 3 through C 8 branched hyroxyalkyl group, and a C 3 through C 6 hydroxycycloalkyl group.

17 . The antimicrobial composition of claim 15 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 8 straight chain alkyl.

18 . The antimicrobial composition of claim 15 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 8 branched alkyl.

19 . The antimicrobial composition of claim 15 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of a C 3 through C 6 cycloalkyl.

20 . The antimicrobial composition of claim 15 wherein at least one of R 1 , R 2 , R 3 , R 4 and R 5 is selected from the group consisting of methylethyl and 2-methylpropyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2007
From: PFIZER INC; PFIZER PRODUCTS INC; PFIZER JAPAN INC; G.D. SEARLE LLC; PHARMACIA CORPORATION; PHARMACIA & UPJOHN COMPANY LLC; WARNER LAMBERT COMPANY LLC
To: MCNEIL-PPC, INC
Reel/Frame 019573/0631 →
CHANGE OF NAME Recorded Mar 13, 2007
From: WARNER-LAMBERT COMPANY
To: WARNER-LAMBERT COMPANY LLC
Reel/Frame 018997/0824 →